Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

TAS-119 × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

Cisplatin 147 pembrolizumab 129 Carboplatin 124 Injections 108 Pemetrexed 98 Paclitaxel 97 Gemcitabine 84 Irinotecan 75 Cyclophosphamide 72 Nivolumab 70 Docetaxel 68 Bevacizumab 60 Oxaliplatin 51 Fluorouracil 51 Capecitabine 48 atezolizumab 46 Leucovorin 43 Etoposide 42 tislelizumab 40 toripalimab 36 Drug Therapy 32 fludarabine 31 Topotecan 29 Ipilimumab 29 durvalumab 28 Vincristine 27 Early Intervention, Educational 27 Specimen Handling 26 Radiotherapy 26 Filgrastim 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02448589 2024-09-04

An Investigation of TAS-119 Monotherapy

Taiho Oncology, Inc.

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡